Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Current transfusion practices.

L E Pierce, C L Beall

    American Family Physician
    |March 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Using packed red blood cells (PRBC) and plasma components offers targeted blood replacement, reducing risks associated with whole blood transfusions like circulatory overload and transfusion reactions. Frozen PRBC further minimize sensitization and disease transmission risks.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Mefenoxam-Resistant Isolates of Pythium irregulare in an Ornamental Greenhouse in California.

    Plant disease·2019
    Same author

    Thiotepa and fractionated TBI conditioning prior to allogeneic stem cell transplantation for advanced hematologic malignancies: a phase II single institution trial.

    Bone marrow transplantation·2004
    Same author

    Metallothionein isoform 3 overexpression is associated with breast cancers having a poor prognosis.

    The American journal of pathology·2001
    Same author

    'False-positive' pregnancy tests pretransplant.

    Bone marrow transplantation·1998
    Same author

    Guidelines for the use of blood transfusions.

    The West Virginia medical journal·1995
    Same author

    B-cell surface phenotypes of proliferating myeloma cells: target antigens for immunotherapy.

    American journal of hematology·1990
    Same journal

    For Post-stent Patients With Atherosclerotic Coronary Vascular Disease Who Are Taking an Anticoagulant, Adding Aspirin Worsens Outcomes.

    American family physician·2026
    Same journal

    Nausea and Vomiting During Pregnancy.

    American family physician·2026
    Same journal

    Metabolic Dysfunction-Associated Steatotic Liver Disease: Diagnosis and Management.

    American family physician·2026
    Same journal

    Aerobic Exercise Is the Better Exercise Modality for Knee Osteoarthritis.

    American family physician·2026
    Same journal

    Overscreening Leads to Overdiagnosis of MASLD.

    American family physician·2026
    Same journal

    Type 2 Diabetes: Outpatient Insulin Management.

    American family physician·2026
    See all related articles

    Area of Science:

    • Transfusion Medicine
    • Hematology

    Background:

    • Whole blood transfusions carry inherent risks.
    • Component therapy allows for precise replacement of blood elements.

    Purpose of the Study:

    • To highlight the advantages of using packed red blood cells (PRBC) and plasma components.
    • To compare the safety profiles of component therapy versus whole blood transfusion.

    Main Methods:

    • Review of transfusion practices.
    • Analysis of risks associated with different blood products.

    Main Results:

    • PRBC transfusion reduces risks of circulatory overload and nonhemolytic transfusion reactions compared to whole blood.
    • Frozen PRBC minimize risks of leukocyte/platelet sensitization.

    Related Experiment Videos

  • Hepatitis transmission is rare with frozen PRBC.

    • Conclusions:

    • Component therapy, specifically PRBC and plasma, provides a safer alternative to whole blood.
    • Utilizing specific blood components minimizes transfusion-related complications and risks.